Home | Relinking the pharma supply chain
In this issue
Contents
Mimotopes Company Insight
Mimotopes
Datwyler Company Insight
Datwyler
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
ILC Dover
Butterworth
Comment
New Chinese Breakthrough Therapy designation attracts foreign companies
Endometrial cancer patients expected to benefit from novel advancements
Regulatory and strategic complications of marketing an oncology drug in Asia
The biopharma revolution: navigating complexity
TRiBECA Knowledge
PerkinElmer
In Depth
What’s in a drug name?
Improving care for rare diseases in India
Focus on the patient, not the pill
Academic-industry collaboration
Rewriting the pharma supply chain for a post-pandemic world
Developing an oral Covid-19 vaccine
The Solubility Company - Company Insight
The Solubility company
In Data
Deals analysis
The pharma industry key list
Global markets and indices
Macro-economic indicators
Macro-economic indicators (page 2)
Events
Next issue
06/01/2021 00:00:00
Go to article:
Home | Relinking the pharma supply chain
Go to article:
In this issue
Go to article:
Contents
Go to article:
Mimotopes Company Insight
Go to article:
Mimotopes
Go to article:
Datwyler Company Insight
Go to article:
Datwyler
Go to article:
Briefing
Go to article:
Industry news
Go to article:
The pharma industry briefing
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
ILC Dover
Go to article:
Butterworth
Go to article:
Comment
Go to article:
New Chinese Breakthrough Therapy designation attracts foreign companies
Go to article:
Endometrial cancer patients expected to benefit from novel advancements
Go to article:
Regulatory and strategic complications of marketing an oncology drug in Asia
Go to article:
The biopharma revolution: navigating complexity
Go to article:
TRiBECA Knowledge
Go to article:
PerkinElmer
Go to article:
In Depth
Go to article:
What’s in a drug name?
Go to article:
Improving care for rare diseases in India
Go to article:
Focus on the patient, not the pill
Go to article:
Academic-industry collaboration
Go to article:
Rewriting the pharma supply chain for a post-pandemic world
Go to article:
Developing an oral Covid-19 vaccine
Go to article:
The Solubility Company - Company Insight
Go to article:
The Solubility company
Go to article:
In Data
Go to article:
Deals analysis
Go to article:
The pharma industry key list
Go to article:
Global markets and indices
Go to article:
Macro-economic indicators
Go to article:
Macro-economic indicators (page 2)
Go to article:
Events
Go to article:
Next issue